The improvement of motor symptoms in Huntington's disease during cariprazine treatment.

"Declarations Ethics approval and consent to participateThe Hungarian National Institute of Pharmacy and Nutrition granted permission for the off-label use of cariprazine for all participants. Ethical approval of the study was issued by the Regional, Institutional Scientific and Research Ethics Committee. The study was conducted in accordance with the Declaration of Helsinki, with the written informed consent of all participants. Consent for publicationInformed consent for publication was provided by the participants. Competing interestsRC, KA and GN are employees of Gedeon Richter Plc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Competing interests RC, KA and GN are employees of Gedeon Richter Plc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

"Funding Open access funding provided by Semmelweis University. The study was supported by TKP2021-NVA-15, TKP2021-EGA-25, OTKA 139010 grants. Open access funding provided by Semmelweis University."